openPR Logo
Press release

Regenerative Medicine Market, Grew To $39,325 Million By 2023

06-06-2018 07:34 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Beam Market

Regenerative Medicine Market, Grew To $39,325 Million By 2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines repair, replace, and regenerate tissues and organs affected due to injury, disease, or natural ageing process. These medicines help restore the functionality of cells & tissues and are applicable in numerous degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications. Researchers focus on developing technologies based on biologics, genes, somatic as well as stem cells. Stem cells are capable of proliferation and differentiation and hence, are critical in this field.

For More Info, Get Sample : https://www.researchbeam.com/regenerative-medicines-market/request-sample

The major factors that boost the market growth include technological advancements in tissue and organ regeneration, increase in prevalence of chronic diseases and trauma emergencies, prominent potential of nanotechnology, and emergence of stem cell technology. In addition, rise in degenerative diseases and shortage of organs for transplantation are expected to fuel the growth of the market. Moreover, utilization of nanomaterials in wound care, drug delivery, and immunomodulation has opened numerous growth avenues for the regenerative medicines market. However, stringent regulatory barriers and high cost of the treatment are likely to hinder the market growth.

The global regenerative medicine market is segmented based on product type, material, application, and geography. Based on product type, the market is classified into cell therapy, gene therapy, tissue engineering, and small molecule & biologic. Depending on material, it is categorized into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical. Synthetic material is further divided into biodegradable synthetic polymer, scaffold, artificial vascular graft material, and hydrogel material. Biologically derived material is further bifurcated into collagen and xenogenic material. Genetically engineered material is further segmented into deoxyribonucleic acid, transfection vector, genetically manipulated cell, three-dimensional polymer technology, transgenic, fibroblast, neural stem cell, and gene-activated matrices. Pharmaceutical is further divided into small molecule and biologic. By application, it is categorized into cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. Geographically, it is analyzed across four regions, i.e., North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STAKEHOLDERS

• This report offers a detailed quantitative analysis of the market trends from 2016 to 2023 to identify the prevailing opportunities.
• The market estimations provided in this report are based on a comprehensive analysis of the key developments in the industry.
• An in-depth analysis based on geography facilitates the study of the regional market to assist in strategic business planning.
• The development strategies adopted by the key manufacturers are enlisted in the report to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

Enquire About Report : https://www.researchbeam.com/regenerative-medicines-market/enquire-about-report

By Product Type

• Cell Therapy
• Gene Therapy
• Tissue Engineering
• Small Molecule & Biologic

By Material

• Synthetic Material
• Biodegradable Synthetic Polymer
• Scaffold
• Artificial Vascular Graft Material
• Hydrogel Material
• Biologically Derived Material
• Collagen
• Xenogeneic Material
• Genetically Engineered Material
• Deoxyribonucleic Acid Transfection Vectors
• Genetically Manipulated Cell
• Three-Dimensional Polymer Technology
• Transgenic
• Fibroblast
• Neural Stem Cell
• Gene-Activated Matrices
• Pharmaceuticals
• Small Molecule
• Biologic

By Application

• Cardiovascular
• Oncology
• Dermatology
• Musculoskeletal
• Wound Healing
• Ophthalmology
• Neurology
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Netherlands
• Sweden
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• Singapore
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• Rest of LAMEA

Also Request For Discount : https://www.researchbeam.com/regenerative-medicines-market/purchase-enquiry

KEY PLAYERS PROFILED

• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Medtronic Plc.
• Athersys, Inc.
• U.S. Stem Cell, Inc. (Bioheart, Inc.)
• Organogenesis, Inc. (Advanced Biohealing)
• Integra Lifesciences Holdings Corporation
• Acelity Holdings, Inc.
• Isto Biologics (Isto Biologics Medical Systems, Inc.)
• CryoLife, Inc.

The other players of the Regenerative Medicine market include (companies not profiled in the report):

• Shimadzu Recursion Pharmaceuticals, Inc.
• Baxter International, Inc.
• DePuy Synthes
• Siemens Healthineers
• General Electric (GE) Company
• Koninklijke Philips N.V.
• Cloudmedx, Inc.
• Bay Labs, Inc.

Table Of Content

• CHAPTER 1: INTRODUCTION
• CHAPTER 2: EXECUTIVE SUMMARY
• CHAPTER 3: MARKET OVERVIEW
• CHAPTER 4: REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE
• CHAPTER 5: REGENERATIVE MEDICINE MARKET, BY MATERIAL
• CHAPTER 6: REGENERATIVE MEDICINE MARKET, BY APPLICATION
• CHAPTER 7: REGENERATIVE MEDICINE MARKET, BY REGION
• CHAPTER 8: COMPANY PROFILES

About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Regenerative Medicine Market, Grew To $39,325 Million By 2023 here

News-ID: 1071877 • Views:

More Releases from Research Beam Market

Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% From 2017 To 2023.
Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period
Intermittent Catheters Market Reach $2,950.7 Million By 2023
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in

All 5 Releases


More Releases for CHAPTER

SISA’s Dharshan Shanthamurthy Addresses ISACA Bangalore Chapter
Bengaluru May 1, 2019: SISA Information Security, a global payment security specialist, announced that Mr. Dharshan Shanthamurthy, Founder and CEO, SISA Information Security recently delivered an informative address on payment security to the ISACA Bangalore Chapter on Saturday 27th April 2019. Mr. Shanthamurthy drew from his own first hand observations of the payment industry, garnered over the years. He spoke about emerging trends in the payments industry, including some of
Chapter 4 of 'Meri Pyaari Bindu'
While the first three chapters of Ayushmann Khurrana and Parineeti Chopra starrer 'Meri Pyari Bindu' tickled our funny bones, the fourth chapter has already made its way. Parineeti shared it on her Twitter handle by tweeting, "So easy to scandalise Abhi's MOM!!! Hahhahahaha here is Chapter 4 :) Bindu v/s Ma 😎😎😎 #MeriPyaariBindu." The chapter 4 shows Tom and Jerry equation between Bindu and Abhimanyu's mom. Bindu, who is Abhi's neighbour
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Robert Wolf as the new Chapter President of AFEA’s Orange, CA Chapter. With the addition of Robert Wolf as the new Chapter President, AFEA is expanding
AFEA Welcomes New Chapter President
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Anthony Cucchi as the new Chapter President of AFEA’s Newton Square, PA Chapter. With the addition of Anthony Cucchi as the new Chapter President, AFEA is expanding its geographical footprint to cover
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Angelica Jones as the new Chapter President of AFEA’s Glendale, California Chapter. With the addition of Angelica Jones as the new Chapter President, AFEA is expanding
SPS/GZ to Present at the Chapter Meeting of the Chicago Chapter of the NASPP
Chicago, IL, October 20, 2010 -- Stock Plan Solutions/Green Zapato LLC (SPS/GZ), a leader in equity compensation administration and outsourcing today announced that Rick Zatz, CEP, will be presenting at the meeting of the Chicago Chapter of the NASPP in October 27, 2010. The U.S. Treasury Department issued the final regulations relating to the return information statement requirements under IRC 6039. These regulations impose return and information statement reporting requirements on